Comparative Diagnostic Performance of Conventional DST, Line Probe Assay, and GeneXpert MTB/RIF in Extrapulmonary Tuberculosis Cases
International Journal of Current Pharmaceutical Review and Research · 31.05.2026 · 18 (05)
DOI: 10.25258/ijcpr.18.5.238 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.05.2026. Verfasst von Mayuri K. S und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Extrapulmonary tuberculosis (EPTB) poses significant diagnostic challenges due to its paucibacillary nature and diverse clinical presentations. Rapid and accurate detection, along with early identification of drug resistance, is essential for effective disease management. Molecular diagnostic tools such as GeneXpert MTB/RIF and Line Probe Assay have emerged as important alternatives to conventional methods.
Methods
A cross-sectional observational study was conducted among 294 patients with suspected extrapulmonary tuberculosis. Clinical specimens were subjected to smear microscopy, culture with drug susceptibility testing (DST), GeneXpert, and Line Probe Assay. Diagnostic performance parameters including sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated using both composite reference standard (CRS) and culture-based methods.
Results
GeneXpert demonstrated higher sensitivity (87.5% using CRS; 83.9% vs culture) compared to LPA (81.2% and 78.0%, respectively), while LPA showed higher specificity (93.5% vs CRS; 92.0% vs culture). GeneXpert showed superior detection in smear-negative (31.9%) and HIV-positive cases (64.7%). Rifampicin resistance detection was comparable across culture DST (19.6%), GeneXpert (18.8%), and LPA (20.2%), with substantial agreement (κ = 0.69–0.74; p < 0.001).
Conclusion
GeneXpert is a highly sensitive and rapid diagnostic tool for extrapulmonary tuberculosis, while LPA provides higher specificity and reliable resistance detection. Integration of molecular diagnostics with conventional culture methods can significantly improve early diagnosis and management of EPTB.
Zitieren
APA
S, M. K., Reddy, E. S., & Vijayvergia, B. (2026). Comparative Diagnostic Performance of Conventional DST, Line Probe Assay, and GeneXpert MTB/RIF in Extrapulmonary Tuberculosis Cases. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.238
Vancouver
S MK, Reddy ES, Vijayvergia B. Comparative Diagnostic Performance of Conventional DST, Line Probe Assay, and GeneXpert MTB/RIF in Extrapulmonary Tuberculosis Cases. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.238
BibTeX
@article{S2026,
author = {S, Mayuri K. and Reddy, Elavarthi Srikaanth and Vijayvergia, Bhawini},
title = {Comparative Diagnostic Performance of Conventional DST, Line Probe Assay, and GeneXpert MTB/RIF in Extrapulmonary Tuberculosis Cases},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {05},
doi = {10.25258/ijcpr.18.5.238}
}
EUVIMED